Unknown

Dataset Information

0

Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination.


ABSTRACT: The development of influenza A virus (IAV) vaccines capable of inducing cytotoxic CD8 T cell responses could potentially provide superior, long-term protection against multiple, heterologous strains of IAV. Although prior studies demonstrated the effectiveness of baculovirus-derived virus-like particle (VLP) vaccination in generating Ab-mediated protection, the role that CD8 T cell immunity plays in overall VLP-mediated protection is less-well understood. In this article, we demonstrate that intranasal vaccination of mice with a VLP containing the hemagglutinin and matrix 1 proteins of IAV/PR/8/34 leads to a significant increase in hemagglutinin 533-specific CD8 T cells in the lungs and protection following subsequent homologous challenge with IAV. VLP-mediated protection was significantly reduced by CD8 T cell depletion, indicating a critical role for CD8 T cells in protective immunity. Importantly, our results show that VLP vaccine-induced CD8 T cell-mediated protection is not limited to homologous IAV strains. VLP vaccination leads to an increase in protection following heterosubtypic challenge with a strain of IAV that avoids vaccine-induced neutralizing Abs but contains conserved, immunodominant CD8 T cell epitopes. Overall, our results demonstrate the ability of influenza protein-containing VLPs to prime IAV-specific CD8 T cell responses that contribute to protection from homo- and heterosubtypic IAV infections. These results further suggest that vaccination strategies focused on the development of cross-protective CD8 T cell responses may contribute to the development of "universal" IAV vaccines.

SUBMITTER: Hemann EA 

PROVIDER: S-EPMC3777857 | biostudies-literature | 2013 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination.

Hemann Emily A EA   Kang Sang-Moo SM   Legge Kevin L KL  

Journal of immunology (Baltimore, Md. : 1950) 20130724 5


The development of influenza A virus (IAV) vaccines capable of inducing cytotoxic CD8 T cell responses could potentially provide superior, long-term protection against multiple, heterologous strains of IAV. Although prior studies demonstrated the effectiveness of baculovirus-derived virus-like particle (VLP) vaccination in generating Ab-mediated protection, the role that CD8 T cell immunity plays in overall VLP-mediated protection is less-well understood. In this article, we demonstrate that int  ...[more]

Similar Datasets

| S-EPMC1866067 | biostudies-literature
| S-EPMC3067975 | biostudies-literature
| S-EPMC5805130 | biostudies-literature
| S-EPMC6908683 | biostudies-literature
| S-EPMC3900655 | biostudies-literature
| S-EPMC3302411 | biostudies-literature
| S-EPMC6863986 | biostudies-literature
| S-EPMC3634000 | biostudies-literature
| S-EPMC7291249 | biostudies-literature
| S-EPMC5555299 | biostudies-other